Applicable Procedure Codes: 11920, 11921, 11922, 11970, 11971, 15271, 15272, 15771, 15772, 15777, 19316, 19325, 19328, 19330, 19340, 19342, 19350, 19355, 19357, 19361, 19364, 19367, 19368, 19369, 19370, 19371, 19396, 19499, L8600, S2066, S2067, S2068, S8950
doi:10.1038/srep38310 Okuda M, Inoue N, Azumi H, et al
Edema: reduce dose by 0.05 mg and elevate legs
Speed to Start Telehealth GLP-1 providers are significantly faster no travel, no scheduling delays
A liverfirst approach includes: Confirming liver involvement with imaging and fibrosis assessments Evaluating comorbid metabolic conditions Tailoring lifestyle guidance to support hepatic outcomes Initiating GLP1s where appropriate for both metabolic and liver health Monitoring ALT/AST and noninvasive fibrosis scores alongside traditional outcomes Even in patients with normal A1C or lean body type, these therapies can play a role
The Safety and Efficacy of Growth Hormone Secretagogues. International Journal of Clinical Endocrinology & Metabolism, vol